Market Cap 7.64M
Revenue (ttm) 0.00
Net Income (ttm) -12.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 74,800
Avg Vol 387,730
Day's Range N/A - N/A
Shares Out 5.16M
Stochastic %K 58%
Beta 0.95
Analysts Strong Sell
Price Target $19.33

Company Profile

MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. The company develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus; and DA-1726, a novel...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 702 9600
Address:
545 Concord Avenue, Suite 210, Cambridge, United States
JimmyOcarri
JimmyOcarri Aug. 17 at 8:40 PM
0 · Reply
ZacksSCR
ZacksSCR Aug. 12 at 4:23 PM
$MTVA: Dose Titration Complete in Phase 1 Part 3 Study of DA-1726 https://buff.ly/mTXpHUA
0 · Reply
gilsoo
gilsoo Aug. 3 at 1:49 PM
$MTVA Early initiative, foresight, and good fortune have worked nicely for Dong-A, elements any organization can benefit from when outsourcing development and manufacturing. And there’s an interesting aside to add here before we end. Ambiopharm recently announced a $121.9 million investment to expand its South Carolina campus “and bring commercial-scale peptide API production to U.S. soil by 2027.” More good fortune for MetaVia? We’ll be following along.
1 · Reply
Merlintrader
Merlintrader Aug. 1 at 8:14 AM
MetaVia Inc. (Nasdaq: $MTVA) Stock Hub: DA-1726 Q4 2026 Obesity Catalyst, Cash Runway, Warrants and Reverse-Split Risk https://www.merlintrader.com/metavia-inc-stock-hub/
0 · Reply
gilsoo
gilsoo Jul. 31 at 12:58 PM
$MTVA Still acting like a broken record, thinking you know it all. So, did that make you rich yet?
0 · Reply
Kertzi
Kertzi Jul. 27 at 9:57 AM
$MTVA ALL TIME HIGH over $600,000 per share!
0 · Reply
Kertzi
Kertzi Jul. 15 at 7:03 PM
$MTVA Novos Oral Wegovy just got approved in the EU (15 July 2026) — 5th market globally after US, UK, UAE.... 2M+ prescriptions in the US alone, 17% weight loss, already profitable. DA-1726 is still Phase 1. Cash gone Q4. No funding for Phase 2. This "obesity play" might never make it to Phase 2, let alone market — a DECADE behind a drug that's already commercial worldwide. 🐻
0 · Reply
stocktraderbegins
stocktraderbegins Jul. 14 at 2:41 PM
$SPY $MTVA great price 🔥🙏💙 Lets ride it up !!!
0 · Reply
Merlintrader
Merlintrader Jul. 14 at 10:46 AM
$MTVA MetaVia Stock Hub - DA-1726 obesity data, the Q4 2026 Phase 1 Part 3 catalyst, the Dong-A ST Korea link, and the dilution equation https://www.merlintrader.com/metavia-inc-stock-hub/
1 · Reply
MACnTEEZ
MACnTEEZ Jul. 13 at 7:51 PM
$MTVA theres an offering filed
2 · Reply
Latest News on MTVA
MetaVia Earnings release: Q2 2026

Aug 6, 2026, 9:30 AM EDT - 12 days ago

MetaVia Earnings release: Q2 2026


MetaVia Quarterly report: Q2 2026

Aug 6, 2026, 9:30 AM EDT - 12 days ago

MetaVia Quarterly report: Q2 2026


MetaVia Slides: Investor presentation

Aug 6, 2026, 8:00 AM EDT - 13 days ago

MetaVia Slides: Investor presentation


MetaVia Transcript: Life Sciences Virtual Investor Forum

Jun 24, 2026, 10:30 AM EDT - 7 weeks ago

MetaVia Transcript: Life Sciences Virtual Investor Forum


MetaVia Transcript: Emerging Growth Conference 93

Jun 11, 2026, 3:40 PM EDT - 2 months ago

MetaVia Transcript: Emerging Growth Conference 93


MetaVia Transcript: AGM 2026

Jun 8, 2026, 10:00 AM EDT - 2 months ago

MetaVia Transcript: AGM 2026


MetaVia presents data at ADA supporting DA-1726, vanoglipel

2026-06-08T12:48:08.000Z - 2 months ago

MetaVia presents data at ADA supporting DA-1726, vanoglipel


3 Penny Stocks to Watch Now, 5/21/26

2026-05-21T19:20:55.000Z - 3 months ago

3 Penny Stocks to Watch Now, 5/21/26

HCWB SLXN


MetaVia Earnings release: Q1 2026

May 14, 2026, 4:00 PM EDT - 3 months ago

MetaVia Earnings release: Q1 2026


MetaVia Quarterly report: Q1 2026

May 14, 2026, 4:00 PM EDT - 3 months ago

MetaVia Quarterly report: Q1 2026


MetaVia Slides: Investor presentation

May 14, 2026, 7:00 AM EDT - 3 months ago

MetaVia Slides: Investor presentation


MetaVia Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 4 months ago

MetaVia Proxy statement: Proxy filing


MetaVia Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 4 months ago

MetaVia Proxy statement: Proxy filing


MetaVia: Cash position adequate to fund operations into 4Q26

2026-03-26T12:43:01.000Z - 5 months ago

MetaVia: Cash position adequate to fund operations into 4Q26


MetaVia Annual report: Q4 2025

Mar 26, 2026, 8:30 AM EDT - 5 months ago

MetaVia Annual report: Q4 2025


MetaVia Earnings release: Q4 2025

Mar 26, 2026, 8:30 AM EDT - 5 months ago

MetaVia Earnings release: Q4 2025


MetaVia Slides: Investor presentation

Mar 26, 2026, 7:00 AM EDT - 5 months ago

MetaVia Slides: Investor presentation


MetaVia Transcript: Life Sciences Virtual Investor Forum

Mar 12, 2026, 10:30 AM EDT - 5 months ago

MetaVia Transcript: Life Sciences Virtual Investor Forum


MetaVia Transcript: Emerging Growth Virtual Conference

Feb 25, 2026, 10:15 AM EST - 6 months ago

MetaVia Transcript: Emerging Growth Virtual Conference


MetaVia Registration statement: Registration Filing

Jan 12, 2026, 7:00 AM EST - 7 months ago

MetaVia Registration statement: Registration Filing


MetaVia Registration statement: Registration Filing

Jan 5, 2026, 7:00 AM EST - 8 months ago

MetaVia Registration statement: Registration Filing


MetaVia Inc. Announces 1-for-11 Reverse Stock Split

Dec 2, 2025, 8:45 AM EST - 9 months ago

MetaVia Inc. Announces 1-for-11 Reverse Stock Split


MetaVia Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

MetaVia Quarterly report: Q3 2025


MetaVia Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

MetaVia Earnings release: Q3 2025


MetaVia Quarterly report: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 1 year ago

MetaVia Quarterly report: Q2 2025


MetaVia Earnings release: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 1 year ago

MetaVia Earnings release: Q2 2025


MetaVia Registration statement: Registration Filing

Jul 2, 2025, 8:00 AM EDT - 1 year ago

MetaVia Registration statement: Registration Filing


MetaVia Transcript: Life Sciences Investor Forum

Jun 12, 2025, 1:00 PM EDT - 1 year ago

MetaVia Transcript: Life Sciences Investor Forum


MetaVia Proxy statement: Proxy Filing

Jun 10, 2025, 8:00 AM EDT - 1 year ago

MetaVia Proxy statement: Proxy Filing


MetaVia Proxy statement: Proxy Filing

May 27, 2025, 8:00 AM EDT - 1 year ago

MetaVia Proxy statement: Proxy Filing


MetaVia Transcript: Emerging Growth Conference 82

May 21, 2025, 4:25 PM EDT - 1 year ago

MetaVia Transcript: Emerging Growth Conference 82


MetaVia Slides: Investor Presentation

May 21, 2025, 7:00 AM EDT - 1 year ago

MetaVia Slides: Investor Presentation


MetaVia Quarterly report: Q1 2025

May 14, 2025, 12:00 AM EDT - 1 year ago

MetaVia Quarterly report: Q1 2025


MetaVia Earnings release: Q1 2025

May 14, 2025, 12:00 AM EDT - 1 year ago

MetaVia Earnings release: Q1 2025


MetaVia Slides: Investor Presentation

Apr 15, 2025, 7:00 AM EDT - 1 year ago

MetaVia Slides: Investor Presentation


MetaVia Annual report: Q4 2024

Mar 20, 2025, 7:30 AM EDT - 1 year ago

MetaVia Annual report: Q4 2024


MetaVia Earnings release: Q4 2024

Mar 20, 2025, 7:30 AM EDT - 1 year ago

MetaVia Earnings release: Q4 2024


MetaVia Slides: Study Result

Jan 9, 2025, 7:00 AM EST - 1 year ago

MetaVia Slides: Study Result


MetaVia Slides: Investor Presentation

Dec 2, 2024, 7:00 AM EST - 1 year ago

MetaVia Slides: Investor Presentation


MetaVia Quarterly report: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

MetaVia Quarterly report: Q3 2024


MetaVia Earnings release: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

MetaVia Earnings release: Q3 2024


JimmyOcarri
JimmyOcarri Aug. 17 at 8:40 PM
0 · Reply
ZacksSCR
ZacksSCR Aug. 12 at 4:23 PM
$MTVA: Dose Titration Complete in Phase 1 Part 3 Study of DA-1726 https://buff.ly/mTXpHUA
0 · Reply
gilsoo
gilsoo Aug. 3 at 1:49 PM
$MTVA Early initiative, foresight, and good fortune have worked nicely for Dong-A, elements any organization can benefit from when outsourcing development and manufacturing. And there’s an interesting aside to add here before we end. Ambiopharm recently announced a $121.9 million investment to expand its South Carolina campus “and bring commercial-scale peptide API production to U.S. soil by 2027.” More good fortune for MetaVia? We’ll be following along.
1 · Reply
Merlintrader
Merlintrader Aug. 1 at 8:14 AM
MetaVia Inc. (Nasdaq: $MTVA) Stock Hub: DA-1726 Q4 2026 Obesity Catalyst, Cash Runway, Warrants and Reverse-Split Risk https://www.merlintrader.com/metavia-inc-stock-hub/
0 · Reply
gilsoo
gilsoo Jul. 31 at 12:58 PM
$MTVA Still acting like a broken record, thinking you know it all. So, did that make you rich yet?
0 · Reply
Kertzi
Kertzi Jul. 27 at 9:57 AM
$MTVA ALL TIME HIGH over $600,000 per share!
0 · Reply
Kertzi
Kertzi Jul. 15 at 7:03 PM
$MTVA Novos Oral Wegovy just got approved in the EU (15 July 2026) — 5th market globally after US, UK, UAE.... 2M+ prescriptions in the US alone, 17% weight loss, already profitable. DA-1726 is still Phase 1. Cash gone Q4. No funding for Phase 2. This "obesity play" might never make it to Phase 2, let alone market — a DECADE behind a drug that's already commercial worldwide. 🐻
0 · Reply
stocktraderbegins
stocktraderbegins Jul. 14 at 2:41 PM
$SPY $MTVA great price 🔥🙏💙 Lets ride it up !!!
0 · Reply
Merlintrader
Merlintrader Jul. 14 at 10:46 AM
$MTVA MetaVia Stock Hub - DA-1726 obesity data, the Q4 2026 Phase 1 Part 3 catalyst, the Dong-A ST Korea link, and the dilution equation https://www.merlintrader.com/metavia-inc-stock-hub/
1 · Reply
MACnTEEZ
MACnTEEZ Jul. 13 at 7:51 PM
$MTVA theres an offering filed
2 · Reply
stockWare
stockWare Jul. 13 at 4:47 PM
$MTVA this biotech is working on a GLP-1 analog $LLY $HIMS $NVO
1 · Reply
stockWare
stockWare Jul. 13 at 4:45 PM
$MTVA got a small position, feels like HC Wainwright is going to bring this to the next level soon and we could be back near 52 week highs very soon. $IWM
0 · Reply
Reliantroofing
Reliantroofing Jul. 13 at 4:20 PM
$MTVA that's how Chinese people make the dollars pump and dump always
1 · Reply
Kertzi
Kertzi Jul. 13 at 4:15 PM
$MTVA MASSIVE PUMP & DUMP! It seems that the next offering has been decided, at which point toxic lenders pumped up the stock price to maximize their profits, before the new shares hit the market. The SEC should investigate these cases, but it’s a waste of time—who cares about a fake Korean pharma company with eight employees?
1 · Reply
Kertzi
Kertzi Jul. 13 at 3:22 PM
0 · Reply
stocktraderbegins
stocktraderbegins Jul. 13 at 3:16 PM
$SPY $MTVA is going offf pile in !!!!
0 · Reply
Stock_Catcher
Stock_Catcher Jul. 13 at 3:11 PM
$MTVA $ALP $SOBR $BRAI $QTTB Great Moves too
0 · Reply
FaithFilledTrader
FaithFilledTrader Jul. 13 at 3:05 PM
$MTVA 🤔
0 · Reply
Joefreeagent
Joefreeagent Jul. 9 at 2:41 PM
$MTVA Pump with after hours dump day.
0 · Reply
Kertzi
Kertzi Jul. 3 at 4:46 AM
$MTVA Whether the data is good or not, this company is once again circling bankruptcy (last time: 2023 with market cap ~$500K). Yesterday's 424B5 renews the ATM shelf — the mechanism they've used to raise just $2.1M over the past 12 months. Pennies, when Phase 2/3 needs hundreds of millions. The math doesn't work!!! Next step: reverse split up to 1:22. Then more penny-dilution through the same ATM, at a "higher" nominal price that means nothing. This is the death spiral. It grinds quietly in the background and destroys shareholder value every single day — not in one dramatic offering, but through a shelf registration nobody reads. Same company (NeuroBo/MetaVia) Same mechanism, since 2013.
0 · Reply
ZacksSCR
ZacksSCR Jun. 30 at 6:49 PM
$MTVA @otcmarkets Hosts Virtual Investor Presentation with HH Kim, CEO and President, and Marshall Woodworth, CFO of MetaVia, with David Bautz, PhD, Senior Analyst at Zacks SCR https://scr.zacks.com/news/news-details/2026/OTC-Markets-Life-Sciences-Investor-Forum-MetaVia-CEO-HH-Kim-and-CFO-Marshall-Woodworth-with-Zacks-SCRs-David-Bautz/default.aspx
1 · Reply